Business ❯ Finance

Healthcare

Pharmaceuticals Health Insurance Healthcare Companies Insurance Medical Devices Biotechnology Cybersecurity Healthcare Services Biopharmaceuticals Technology Legal Issues Insider Transactions Medicare Hospitals Pharmaceutical Industry GE Healthcare Centene Corporation Hospital Management Clinical Trials Private Hospitals Healthcare Delivery InfuSystems Holdings Government Insider Trading Company Performance Mental Healthcare Insurance Companies Insurance Sector Digital Healthcare Corporate Strategy Hospital Operations Corporate Restructuring Retail Operational Performance Market Trends Oncology Medical Costs Medicare Practices Cost Management Medicare Advantage Motion Sickness Telecommunications Companies Clinical Research Organizations Financial Performance Vaccines Mental Health Conditions Healthcare Stocks

Gilead Posts Q4 Beat on HIV Strength as 2026 Outlook Eases on Policy Headwinds

Guidance reflects policy headwinds from a late-2025 White House pricing pact.

FDA Approves Vanda’s Nereus, First New Motion Sickness Treatment in Over 40 Years

Insulet Beats Q3 Targets and Lifts 2025 Outlook on Surging Omnipod Sales

Guardant Health Shares Hit Record High on Earnings Beat and Raised Sales Guidance

HCA Healthcare Tops Q3 Estimates, Lifts 2025 Outlook, Executes $2.5 Billion Buyback

Elevance Tops Q3, Flags 2026 Medicaid Margin Hit and Keeps 2025 Outlook

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug

Campbell’s Beats Q4 Profit Forecasts, Cuts 2026 Outlook as Tariffs Weigh

CVS Health Tops Q2 Forecasts, Lifts 2025 Earnings Guidance